MK0859 (Anacetrapib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK0859 (Anacetrapib), covering 2015-05-06 to 2015-05-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029) [Phase 2]